TSLP drives acute T(H)2-cell differentiation in lungs.
TSLP drives acute T(H)2-cell differentiation in lungs.
复制标题
DOI:
10.1016/j.jaci.2020.03.032
复制
发表时间:
2020-12
期刊:
影响因子:
--
通讯作者:
Ziegler SF
中科院分区:
文献类型:
--
作者:
Lai JF;Thompson LJ;Ziegler SF
Thymic stromal lymphopoietin (TSLP) is an epithelial-derived cytokine important for the development of type-2 inflammatory responses at mucosal surfaces. In humans, TSLP has been found to be elevated in the lungs of asthmatics, and in mouse models TSLP can promote type-2 airway inflammation, primarily through the activation of dendritic cells. However, the mechanisms underlying its role remain unclear. The objective of this study is to provide a mechanistic analysis of TSLP-mediated type-2 airway inflammation To dissect the mechanisms of TSLP-mediated type II responses, mice were treated with TSLP and antigen to evaluate cellular immune responses. Flow cytometric analyses were used to follow responses in the airways, and conditional deletion of TSLPR and adoptive transfer were used to identify the cellular subsets involved in this inflammatory response. We show that TSLP can directly promote Th2 differentiation in the lung, independent of the draining lymph node. We also identified a population of patrolling monocytes/interstitial macrophages (CD11cIM) that are both necessary and sufficient for TSLP-mediated Th2 differentiation and airway inflammation. Th2-driven airway eosinophilia is attenuated by ablation of CD11cIM, or by selective deficiency of TSLPR signaling in these cells. More importantly, CD11cIM are sufficient for the induction of acute Th2 responses in the lungs that is independent of dendritic cells and T cell priming in the draining LN. These findings indicate a novel mechanistic role for TSLP and CD11cIM in the development of acute Th2-dependent allergic airway inflammation. This work also demonstrates a new role for TSLP in promoting type-2 responses directly in the lung. Our study showed TSLP promotes rapid primary Th2 driven airway inflammation, which provides a novel mechanism in development of inflammation in tissue; and more importantly, a potential explanation for efficacy of anti-TSLP therapy in moderate-to-severe asthmatic patients.
登录
查看更多内容
影响因子:
30.3
作者:
Hohl TM;Rivera A;Lipuma L;Gallegos A;Shi C;Mack M;Pamer EG
通讯作者:
Pamer EG
DOI:
10.4049/jimmunol.1302175
发表时间:
2013-11-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Kitajima M;Ziegler SF
通讯作者:
Ziegler SF
影响因子:
15.9
作者:
Han, Hongwei;Thelen, Tennille D.;Ziegler, Steven F.
通讯作者:
Ziegler, Steven F.
影响因子:
15.9
作者:
Bedoret, Denis;Wallemacq, Hugues;Bureau, Fabrice
通讯作者:
Bureau, Fabrice
影响因子:
5.3
作者:
Jung, S;Aliberti, J;Littman, DR
通讯作者:
Littman, DR